Balyasny Asset Management
ETNB

Balyasny Asset Management’s 89bio ETNB Stock Holding History

Balyasny Asset Management’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,459,055
Closed -$21.4M – 3220
2025
Q3 		$21.4M Buy
+1,459,055
New +$14.9M 0.03% 688
2025
Q2 		– Sell
-336,649
Closed -$2.45M – 2972
2025
Q1 		$2.45M Sell
336,649
-682,800
-67% -$5.97M ﹤0.01% 1612
2024
Q4 		$7.97M Buy
+1,019,449
New +$8.39M 0.01% 1062
2024
Q3 		– Sell
-40,656
Closed -$326K – 2852
2024
Q2 		$326K Buy
40,656
+15,334
+61% +$137K ﹤0.01% 2208
2024
Q1 		$295K Buy
+25,322
New +$280K ﹤0.01% 2268
2023
Q1 		– Sell
-22,159
Closed -$282K – 2799
2022
Q4 		$282K Buy
+22,159
New +$199K ﹤0.01% 2015

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Balyasny Asset Management's ETNB Position: Q4 2025 in Review

Balyasny Asset Management sold out of 89bio (ETNB) in Q4 2025, closing a stake of 1,459,055 shares — an estimated $21.4M sold.

Balyasny Asset Management first reported a position in ETNB in Q4 2022 and held it in 6 quarters. The position peaked at $21.4M in Q3 2025. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Balyasny Asset Management reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 1,459,055 89bio shares in Q4 2025, an estimated $21.4M.
  • Balyasny Asset Management first reported a position in 89bio in Q4 2022 and held it in 6 quarters.
  • Balyasny Asset Management's 89bio position peaked at $21.4M in Q3 2025.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Balyasny Asset Management's 13F filing for Q4 2025, filed 17 Feb 2026.